Every year, over 20 million people globally are diagnosed with cancer and close to 9.5 million people will reportedly succumb ...

Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in over-the-counter Rogaine. The prescription treatment is known, however, to dilate blood ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...

DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.

I read with interest the Nov. 27 Regina Leader-Post article by Larissa Kurz, “Nine new physicians joining cancer clinics.” In ...

A friend, who is a physician, reminded me algorithms in healthcare are only as good as the way they're developed.

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

The data is out there and has never been more important. Now, organizations must make efforts to access SDOH data, dive into ...

Meta-analysis of three trials found that immediate breast surgery in women over 70 cut breast cancer death rates in half ...